MSB 7.69% $1.19 mesoblast limited

Ann: Mesoblast to Evaluate Remestemcel-L in COVID-19 Lung Disease, page-132

  1. 30,315 Posts.
    lightbulb Created with Sketch. 1834
    Everything is lining up. It's time for Silvio and team to have their day in the sun.

    Brace yourselves because the news flow is going to get astonishing.

    It's not just the opportunity financially, it's being able to intervene and save lives and improve quality of life.

    This is the start of a revolution in medicine and we're a small part of it.

    It's a great feeling.


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.